Group 1: Business Expansion and Market Presence - The company currently does not operate in North America but is focusing on Europe, the Middle East, and actively expanding into Latin America, Asia-Pacific, and Africa, with a mature sales network covering multiple countries and regions globally [1] - The company has established overseas production bases in Brazil, Indonesia, Poland, and recently added facilities in Germany and Mexico, with the German factory progressing as planned to serve the European market [2] Group 2: Tender and Contract Achievements - The company has been recommended as a candidate for the first batch of framework tender projects for metering products and distribution network equipment in the Southern Power Grid for 2024, with an expected tender amount of approximately ¥629 million [2] - The pre-tender amount for metering products is approximately ¥380 million, representing a year-on-year increase of 108.12%, while the pre-tender amount for distribution network equipment is approximately ¥249 million, showing a year-on-year increase of 39.64% [2] Group 3: Order Delivery and Hospital Network - The typical order delivery cycle for the company is 1-2 years, with variations in delivery rhythm based on customer requirements and product types [2] - As of the end of 2023, the company operates 28 hospitals, including 22 rehabilitation hospitals, with a total of over 8,800 beds, primarily located in key cities in East, Central, and South China [2]
三星医疗(601567) - 三星医疗投资者关系活动记录表(2024年7月)